Advertisement
Canada markets open in 4 hours 34 minutes

  • S&P/TSX

    21,823.22
    +94.67 (+0.44%)
     

  • S&P 500

    5,064.20
    +45.81 (+0.91%)
     

  • DOW

    38,225.66
    +322.37 (+0.85%)
     

  • CAD/USD

    0.7319
    +0.0006 (+0.08%)
     

  • CRUDE OIL

    79.26
    +0.31 (+0.39%)
     

  • Bitcoin CAD

    81,024.80
    +1,915.77 (+2.42%)
     

  • CMC Crypto 200

    1,285.48
    +8.51 (+0.67%)
     

  • GOLD FUTURES

    2,308.50
    -1.10 (-0.05%)
     

  • RUSSELL 2000

    2,016.11
    +35.88 (+1.81%)
     

  • 10-Yr Bond

    4.5710
    -0.0240 (-0.52%)
     

  • NASDAQ futures

    17,758.75
    +109.00 (+0.62%)
     

  • VOLATILITY

    14.47
    -0.21 (-1.43%)
     

  • FTSE

    8,199.56
    +27.41 (+0.34%)
     

  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     

  • CAD/EUR

    0.6810
    -0.0007 (-0.10%)
     

Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

PR Newswire
·1 min read

ATLANTA, March 6, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate virtually at the upcoming Oppenheimer 34th Annual Healthcare MedTech & Services Conference. The Company's virtual fireside chat is scheduled to begin at 10:40 a.m. ET on March 13, 2023.

(PRNewsfoto/Artivion, Inc.)
(PRNewsfoto/Artivion, Inc.)

A live webcast of the virtual fireside chat will be accessible through Artivion's website, www.artivion.com, on the Investors page. An archived copy of the webcast will be available for 90 days on the same website.

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.Artivion.com.

ADVERTISEMENT

Contacts:

Artivion

Gilmartin Group LLC

Lance A. Berry

Brian Johnston / Laine Morgan

Executive Vice President &

Phone: 332-895-3222

Chief Financial Officer

investors@artivion.com 

Phone: 770-419-3355


 

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-the-oppenheimer-34th-annual-healthcare-medtech--services-conference-302081998.html

SOURCE Artivion, Inc.